The New Drug Application (NDA) for viloxazine hydrochloride (SPN-812; Supernus Pharmaceuticals), a serotonin norepinephrine modulating agent, has been submitted to the Food and Drug Administration (FDA) for the treatment of pediatric patients with attention deficit hyperactivity disorder (ADHD).
Researchers highlighted the need for rapid investigations of vaccine safety concerns to use robust epidemiologic methods to maintain public and professional confidence in vaccination programs.
Less than half of US children have sufficient sleep, which is positively associated with several individual markers and a combined marker of flourishing.
Cognitive behavioral therapy (CBT) may reduce the incidence of insomnia symptoms in adolescents, according to study data presented at the 2019 World Sleep Congress.
Investigators sought to determine the mental health needs of evacuees of devastating wildfires in Canada and to distribute evidence-based tools to promote resilience.
Late chronotype and daytime sleepiness are associated with unhealthy life habits, including consumption of alcohol and caffeinated beverages and smoking high school students.
High intensity interval training may increase serum brain-derived neurotrophic factor levels in patients with idiopathic Parkinson disease, along with improvement of neuroplasticity and quality of life.
Cirrhosis and chronic liver disease are endemic in the veteran population. These conditions — often associated with alcohol and substance use or obesity — can be exacer-bated by posttraumatic stress disorder (PTSD). In turn, PTSD is often linked with great-er mortality from chronic liver disease.
